Uzbekistan vs Western Pacific (WHO region): Measles-containing-vaccine second-dose (MCV2) immunization coverage
Uzbekistan
99.0%
in 2025
Western Pacific (WHO region)
86.0%
in 2025
Uzbekistan rank
1st
Western Pacific (WHO region) rank
4th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Uzbekistan
- Western Pacific (WHO region)
How they compare
Uzbekistan currently reports 99.0% against 86.0% in Western Pacific (WHO region), a difference of 13.0%.
That makes Uzbekistan's figure about 1.2 times Western Pacific (WHO region)'s.
The two have swapped places 2 times across 26 shared years of data; in 2000 it was Uzbekistan ahead.
Uzbekistan ranks 1st and Western Pacific (WHO region) ranks 4th of 194 countries.
Uzbekistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Uzbekistan | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 71.2% | 37.8% | 33.4% | Uzbekistan |
| 2010s | 94.5% | 86.7% | 7.8% | Uzbekistan |
| 2020s | 99.0% | 86.7% | 12.3% | Uzbekistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Uzbekistan or Western Pacific (WHO region)?
- Uzbekistan, at 99.0% against 86.0% in Western Pacific (WHO region) as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Uzbekistan and Western Pacific (WHO region)?
- 13.0%, with Uzbekistan ahead.
- How many years of comparable data are there for Uzbekistan and Western Pacific (WHO region)?
- 26 years are reported by both, from 2000 to 2025.
- How do Uzbekistan and Western Pacific (WHO region) rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Uzbekistan ranks 1st and Western Pacific (WHO region) ranks 4th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.